Yabing Chen

Dr. Yabing Chen is a Professor in the Department of Molecular & Cellular Pathology at the University of Alabama at Birmingham (UAB) School of Medicine. She was recognized as an Outstanding Faculty Senate Committee Member in 2019, reflecting her active engagement in academic governance. Her research primarily focuses on

• Immunotherapy for lymphomas
• Stem cell transplantation
• Post-CAR-T therapy complications
• Health disparities in cancer treatment

Her recent publications highlight clinical trials and real-world analyses of CAR-T cell therapies (e.g., tisagenlecleucel, MB-105), with specific emphasis on

• Lymphoma treatment
• Immune effector cell toxicity
• Long-term patient outcomes
• Minority health equity
• Transplantation-associated complications
• Therapeutic monitoring

She has received recognition for her contributions to immunotherapy research and continues to address critical challenges in hematopoietic malignancies.